ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Risk factors"

  • 2019 American Transplant Congress

    Significance of Histopathologic Features for Predicting Progression in Patients with Transplant Glomerulopathy

    X. Li, J. Chen, D. Cheng, R. Wang, W. Wang, M. Zhang, F. Xu, J. Wen, Z. Tang

    National Clinical Research Center of Kidney Diseases, Nanjing, China

    *Purpose: Transplant glomerulopathy (TG) represents a major cause of long-term allograft failure and is the leading cause of overall post-transplant proteinuria. We aimed to determine…
  • 2019 American Transplant Congress

    Induction with Thymoglobulin in DCD Kidneys. Dose Effect and Predictors of Outcome

    A. Asderakis, T. Sabah, A. Jones, E. Ablorsu, L. Szabó, R. Chavez

    Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom

    *Purpose: Thymoglobulin (ATG) is used only in few UK centres as induction. We have previously shown good results with ATG for pancreas transplants. The aim…
  • 2019 American Transplant Congress

    Alterations in Brain Metabolites before and after Kidney Transplant

    A. Gupta1, P. Lee2, R. Lepping3, A. Jurgensen1, J. Klein1, P. Adany4, D. Cibrik1, J. Burns5, W. Brooks3, I. Choi6

    1Division of Nephrology, The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, 2Hoglund Brain Imaging Center, Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, 3Hoglund Brain Imaging Center, Alzheimer’s Disease Center,, University of Kansas Medical Center, Kansas City, KS, 4Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, KS, 5Alzheimer’s Disease Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 6Hoglund Brain Imaging Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS

    *Purpose: End stage renal disease (ESRD) is associated with accumulation of uremic metabolites and poor cognitive performance. Alterations in brain metabolites are associated with cognitive…
  • 2019 American Transplant Congress

    Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)

    A. Gruessner, S. Saggi, R. W. Gruessner

    SUNY Downstate Medical Center, Brooklyn, NY

    *Purpose: African-American recipients (AA) are considered a high risk group for organ transplantation. As outcomes after pancreas transplantation have significantly improved, the number of transplants…
  • 2019 American Transplant Congress

    Hope Act Donors With Organs Recovered For Transplant: The First Two Years

    W. A. Werbel, O. Kusemiju, B. Barnaba, M. Bowring, B. Doby, C. Kirby, R. Fernandez, Y. Eby, J. Miller, D. Brown, S. Seaman, D. Ostrander, A. Tobian, D. Segev, C. M. Durand

    Johns Hopkins University, Baltimore, MD

    *Purpose: The HOPE Act expands the potential deceased donor pool to include HIV+ donors (HIV D+) and donors with false-positive (FP) HIV screens. The objective…
  • 2019 American Transplant Congress

    Factors Associated with Cardiovascular Subclinical Target Organ Damage in Liver Transplant Recipients

    C. Kuepper1, N. Memaran1, B. Borchert1, A. von Wick1, E. Bauer1, E. Jäckel2, S. Ziegert2, B. M. Schmidt3, A. Melk1

    1Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany, 2Department of Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany, 3Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany

    *Purpose: Liver transplantation (LT) patients are prone to cardiovascular (CV) morbidity, since LT-related factors can add to the burden of classical risk factors. The aim…
  • 2019 American Transplant Congress

    Graft Survival of Fourth Time Renal Transplant Recipients Are Similar to Third Time Transplants: A SRTR Database Analysis

    B. Petrun, R. Nygaard, M. Hill, C. Richardson, A. Israni, P. Stahler

    Hennepin County Medical Center, Minneapolis, MN

    *Purpose: The number of candidates for repeat kidney transplant in the United States has steadily increased over the last 30 years. Second and third kidney…
  • 2019 American Transplant Congress

    Impact Of Rituximab And Maintenance Steroid In The Recurrence Of Focal Segmental Glomerulosclerosis

    L. A. Mendez Castaner

    Transplant, Miami Transplant Institute-University of Miami, Miami, FL

    *Purpose: Recurrence of focal segmental glomerulosclerosis (FSGS) has been reported between 20-80% with up to 60% of graft loss. Rituximab has demonstrated to be effective…
  • 2019 American Transplant Congress

    Similar Quality in Chronic Kidney Disease Multidisciplinary Follow-Up between Kidney Transplant and Pre-Dialysis Patients

    M. Carminatti, N. M. Fernandes, F. A. Colugnati, H. Sanders-Pinheiro

    Nephrology, UFJF, Juiz de Fora, Brazil

    *Purpose: Multidisciplinary clinics are the best approach for pre-dialysis patients (PDP), but few studies depict its impact in kidney transplant recipients (KTR), mostly through comparisons…
  • 2019 American Transplant Congress

    The Incidence of Fungal Infections in Pancreas Transplant Recipients in the Absence of Systemic Antifungal Prophylaxis

    S. Shaikh1, M. Cooper1, A. Nolan1, P. Abrams2

    1MedStar Georgetown University Hospital, Washington, DC, 2MedStar Gerogetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC

    *Purpose: Fungal infections after pancreas transplantation have been associated with morbidity and mortality, therefore transplant centers may elect to use systemic perioperative antifungal prophylaxis (ppx).…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences